Article ID Journal Published Year Pages File Type
2513459 Biochemical Pharmacology 2012 11 Pages PDF
Abstract

The role of endothelial and neural factors as modulators of neurogenic- and noradrenaline-induced vasoconstriction was examined in healthy pig internal mammary artery (IMA). Tetrodotoxin-, guanethidine-sensitive electrical field stimulation (EFS)-, and noradrenaline-elicited contractions were significantly diminished by prazosin (n = 8, P < 0.001) and less so by rauwolscine, indicating functional α1- and α2-adrenoceptor-mediated noradrenergic innervation of the IMA. Endothelium removal reduced neurogenic (n = 8, P < 0.01) but augmented noradrenaline responses (n = 8, P < 0.01), suggesting the release of two endothelium-dependent factors with opposite effects. In the presence of endothelium, neurogenic and exogenous noradrenaline vasoconstrictions were enhanced by l-NOArg (n = 7, P < 0.05 and P < 0.01 respectively) and ODQ (n = 7, both P < 0.05); in denuded arteries, nNOS inhibition with Nω-propyl-l-arginine increased neurogenic contraction (n = 7, P < 0.05). Western blotting indicated the presence of neural and endothelial origin NO (n = 6, P < 0.001). Tetraethylammonium (n = 9, P < 0.001), iberiotoxin (n = 7, P < 0.001) and 4-aminopyridine (n = 8, P < 0.01) enhanced vasoconstrictions revealing a modulatory role of big conductance Ca2+-activated K+ (BKCa) and voltage-dependent K+ (Kv) channels in noradrenergic responses. Bosentan pretreatment (n = 8, P < 0.05) suggested endothelin-1 as the inferred contractile neurogenic endothelial-dependent factor. Indomethacin-induced inhibition involved a muscular prostanoid (n = 9, P < 0.05), functionally and immunologically localized, and derived from cyclooxygenase (COX)-1 and COX-2, as revealed by Western blots (n = 5, P = 0.1267). Thus, noradrenergic IMA contractions are controlled by contractile prostanoid activation and endothelin-1 release, and offset by BKCa and Kv channels and neural and endothelial NO. These results help clarify the mechanisms of vasospasm in IMA, as the preferred vessel for coronary bypass.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology
Authors
, , , , , , , , , ,